Document is current
Any future updates will be listed below
-
Authors
Ullah, Ihsan
Ottlewski, Isabel
Shehzad, Wasim
Riaz, Amjad
Ijaz, Sadaqat
Tufail, Asad
Ammara, Hafiza
Mane, Shrikant
Shril, Shirlee
Hildebrandt, Friedhelm
Zahoor, Muhammad Yasir
Majmundar, Amar J.
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (UM1HG006504)
National Institutes of Health (DK-076683-13, 5K12HD052896-13)
American Society of Nephrology (FP01025169)
Manton Center for Orphan Disease Research, Boston Children's Hospital (Junior Faculty Award)
- License Information
-
More Information
Article History
Received: 16 August 2021
Accepted: 1 November 2021
First Online: 12 November 2021
Declarations
:
: Human subject’s research performed in this study was in accordance with the ethical standards of and approved by the Institutional Review Boards of Boston Children’s Hospital and University of Veterinary and Animal Sciences Lahore, Pakistan. Informed consent was obtained from all NL subjects at time of enrolment to obtain and report clinical data and pedigree information in publications.
: Not applicable.
: F.H. is a co-founder of Goldfinch Biopharma Inc. No other authors declare potential competing interests.
